EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study

Leonardo de Oliveira Harduin iD, Thiago Almeida Barroso, Julia Bandeira Guerra, Márcio Gomes Filippo iD, Leonardo Cortizo de Almeida, Brunno Ribeiro Vieira, Renata Silveira Mello, Adriano Martins Galhardo, Guilherme de Castro-Santos iD, Carlos Eduardo Virgini-Magalhães, Jorge Paulo Strogoff-de-Matos

The Journal of Vascular Access · 2025

DOI: 10.1177/11297298231226259 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Leonardo de Oliveira Harduin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liv Care Centro Clínico, Niterói, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Graft Occlusion, Vascular, Stents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Scitech Medical©.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular stenosis commonly leads to dysfunction in hemodialysis vascular access. Although percutaneous transluminal angioplasty is an established treatment, stent utilization has increased in the last decade as an alternative solution to extend the access function. This study evaluated the safety and initial results of a new impermeable covered stent for treating vascular access outflow stenosis.

Methods

Investigators retrospectively analyzed 114 hemodialysis patients treated with polytetrafluorethylene-covered stents from September 2018 to September 2022 across four centers. Lesions treated were de novo or restenotic and located in the venous graft anastomosis, outflow segment, cephalic arch, and basilic swing point. Patients were followed by in-person physical examination at 1, 3, and 6 months, and Duplex ultrasound was performed to evaluate the vascular access circuit and in-stent restenosis. The primary efficacy endpoint was target lesion primary patency at 1, 3, and 6 months. Secondary endpoints included access circuit primary patency and secondary patency at 1, 3, and 6 months. The primary safety endpoint was freedom from local or systemic serious adverse events through 30 days post-procedure.

Results

Forty-four patients had thrombosed access at the initial presentation, and 41 patients presented with recurrent stenosis. The target lesion primary patency rates at 1, 3, and 6 months were 100%, 89.4%, and 74%, respectively. The access circuit primary patency rates were 100% at 1 month, 85% at 3 months, and 62.7% at 6 months. The secondary patency rates at 1, 3, and 6 months were 100%, 96.4%, and 94.6%, respectively. In the adjusted multivariate Cox regression analysis, only recurrent lesions and female gender were associated with reduced primary patency rates. No serious adverse event was observed through the first 30 days post-procedure.

Conclusion

In this retrospective analysis, a new covered stent was shown to be safe and effective for treating peripheral outflow stenosis in vascular access.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisArteriovenous Shunt, SurgicalGraft Occlusion, VascularStentsBlood Vessel Prosthesis ImplantationEndovascular ProceduresHumansRetrospective StudiesFemaleMaleVascular PatencyMiddle AgedTreatment OutcomeAgedTime FactorsProsthesis DesignBrazilRisk FactorsRecurrenceAdultConstriction, Pathologic

Stichwörter der Autor:innen

Hemodialysiscovered stentstenosisstent graftvascular access

Autor:innen und Institutionen

  • Liv Care Centro Clínico, Niterói, Rio de Janeiro, Brazil.
  • Afya Hospital Dia, Brasília, Distrito Federal, Brazil.
  • Image Department, Hospital Niterói Dor and Centro Clínico LIVCARE, Niterói (Rio de Janeiro), Brazil.
  • Vascular Surgery Service, Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Estado do Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil.
  • Vascular Surgery Service, Hospital Ana Nery, Salvador, Bahia, Brazil.
  • Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Leonardo de Oliveira Harduin, Márcio Gomes Filippo, Guilherme de Castro-Santos

Förderung

  • Scitech Medical©

Zitieren

APA

Harduin, L. O., Barroso, T. A., Guerra, J. B., Filippo, M. G., de Almeida, L. C., Vieira, B. R., Mello, R. S., Galhardo, A. M., Castro-Santos, G., Virgini-Magalhães, C. E., & Strogoff-de-Matos, J. P. (2025). Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study. The Journal of Vascular Access. https://doi.org/10.1177/11297298231226259

Vancouver

Harduin LO, Barroso TA, Guerra JB, Filippo MG, de Almeida LC, Vieira BR, et al. Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study. The Journal of Vascular Access. 2025. doi:10.1177/11297298231226259

BibTeX
@article{Harduin2025,
  author = {Harduin, Leonardo de Oliveira and Barroso, Thiago Almeida and Guerra, Julia Bandeira and Filippo, Márcio Gomes and de Almeida, Leonardo Cortizo and Vieira, Brunno Ribeiro and Mello, Renata Silveira and Galhardo, Adriano Martins and Castro-Santos, Guilherme de and Virgini-Magalhães, Carlos Eduardo and Strogoff-de-Matos, Jorge Paulo},
  title = {Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study},
  journal = {The Journal of Vascular Access},
  year = {2025},
  doi = {10.1177/11297298231226259}
}
Kostenlos starten →